Deutsche Bank Ag\ Aerie Pharmaceuticals Inc Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.37 - $15.23 $1.67 Million - $4 Million	-262,561 Reduced 26.17%	740,882 $11.2 Million
Q2 2022 Aug 11, 2022	BUY	$4.95 - $9.16 $3.56 Million - $6.59 Million	719,744 Added 253.7%	1,003,443 $7.53 Million
Q1 2022 May 13, 2022	SELL	$5.64 - $9.8 $124,559 - $216,433	-22,085 Reduced 7.22%	283,699 $2.58 Million
Q4 2021 Feb 11, 2022	SELL	$7.02 - $13.33 $1.85 Million - $3.51 Million	-263,664 Reduced 46.3%	305,784 $2.15 Million
Q3 2021 Nov 04, 2021	SELL	$11.32 - $16.63 $863,036 - $1.27 Million	-76,240 Reduced 11.81%	569,448 $6.49 Million
Q2 2021 Aug 11, 2021	SELL	$15.16 - $18.97 $859,951 - $1.08 Million	-56,725 Reduced 8.08%	645,688 $10.3 Million
Q1 2021 May 13, 2021	BUY	$13.12 - $20.9 $4.47 Million - $7.12 Million	340,600 Added 94.14%	702,413 $12.6 Million
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $825,551 - $1.31 Million	90,521 Added 33.37%	361,813 $4.89 Million
Q3 2020 Nov 12, 2020	BUY	$10.46 - $14.46 $1.64 Million - $2.27 Million	156,897 Added 137.15%	271,292 $3.19 Million
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $1.04 Million - $1.4 Million	87,036 Added 318.13%	114,395 $1.69 Million
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $55,648 - $119,944	4,700 Added 20.74%	27,359 $369,000
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $57,926 - $82,051	-3,269 Reduced 12.61%	22,659 $546,000
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $2.56 Million - $3.89 Million	-138,920 Reduced 84.27%	25,928 $497,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $2.61 Million - $4.34 Million	89,972 Added 120.16%	164,848 $4.87 Million
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $1.31 Million - $1.77 Million	35,951 Added 92.36%	74,876 $3.56 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $1.93 Million - $3.5 Million	-58,376 Reduced 60.0%	38,925 $1.4 Million
Q3 2018 Dec 21, 2021	BUY	$56.15 - $73.9 $921,309 - $1.21 Million	16,408 Added 20.28%	97,301 $5.99 Million
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $6.75 Million - $8.89 Million	-120,279 Reduced 59.79%	80,893 $4.98 Million
Q2 2018 Apr 21, 2020	BUY	$47.85 - $70.45 $932,022 - $1.37 Million	19,478 Added 10.72%	201,172 $13.6 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $5.58 Million - $8.22 Million	116,640 Added 179.3%	181,694 $12.3 Million
Q1 2018 Oct 18, 2019	BUY	$51.15 - $61.0 $934,715 - $1.11 Million	18,274 Added 39.06%	65,054 $3.53 Million
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $2.12 Million - $2.52 Million	-41,387 Reduced 46.94%	46,780 $2.54 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $482,210 - $617,343	-9,483 Reduced 9.71%	88,167 $5.27 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $4.75 Million - $5.87 Million	97,650	97,650 $4.74 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account